HAEMONETICS CORP (HAE) earnings date
Feb 4, 2027, before open estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q3 FY2027
- Confidence
- 52% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 40 days, typically, give or take 0 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q2 FY2027 | Thu, Nov 5, 2026 | before open | 40 | 8-K |
| Q1 FY2027 | Thu, Aug 6, 2026 | before open | 40 | 8-K |
| Q4 FY2026 | Thu, May 7, 2026 | before open | 40 | 8-K |
| Q3 FY2026 | Thu, Feb 5, 2026 | before open | 40 | 8-K |
| Q2 FY2026 | Thu, Nov 6, 2025 | before open | 40 | 8-K |
| Q1 FY2026 | Thu, Aug 7, 2025 | before open | 40 | 8-K |
| Q4 FY2025 | Thu, May 8, 2025 | before open | 40 | 8-K |
| Q3 FY2025 | Thu, Feb 6, 2025 | before open | 40 | 8-K |
What they guided beta
| Q2 FY2027 | "Manager-Investor Relations (203) 733-4987 david.trenk@haemonetics.com Haemonetics R eports Second Quarter and First Half Fiscal 2027 Results; Updates Fiscal 2027 Guidance Boston, MA, November 5, 2026 - Haemonetics Corporation (NYSE: HAE) reported financial results for its second quarter of fiscal 2027, which ended September 26, 2026: 2nd Quarter 2027 Year-to-Date 2027 n Revenue, increase $358 million, 9% $697 million, 8% n Organic (1) revenue increase 10.0% 8.0% n Earnings per diluted share $1.00 $1.72 n Adjusted earnings per diluted share $1.35 $2.49 n Cash flow from operating activities $128" exhibit |
| Q2 FY2027 | "FISCAL 2027 GUIDANCE The Company updated its previous fiscal 2027 guidance as follows: Total Company Previous Guidance Current Guidance Reported Revenue 5 - 8% 8 - 11% 53rd week impact (~2%) (~2%) Strategic exits (1) ~1% ~1% Currency impact 0 - 1% 0 - 1% Organic Revenue (2) 4 - 7% 6 - 9% Adjusted operating margin 50 – 100 bps expansion YoY 0 – 50 bps expansion YoY Adjusted earnings per diluted share Comparable to reported revenue growth Comparable to reported revenue growth Free cash flow conversion (3) ~80% >80% __________ (1) Includes the impact of the exit of certain liquid solution product" exhibit |
| Q1 FY2027 | "Manager-Investor Relations (203) 733-4987 david.trenk@haemonetics.com Haemonetics R eports First Quarter Fiscal 2027 Results; Raises Total Company Fiscal 2027 Guidance Boston, MA, August 6, 2026 - Haemonetics Corporation (NYSE: HAE) reported financial results for its first quarter of fiscal 2027, which ended June 27, 2026: 1st Quarter 2027 n Revenue, increase $339 million, 5.6% n Organic (1) revenue increase 5.9% n Earnings per diluted share $0.72 n Adjusted earnings per diluted share $1.14 n Cash flow from operating activities $52 million n Free cash flow $39 million __________ (1) Excludes t" exhibit |
| Q1 FY2027 | "We raised full-year guidance, and Haemonetics is well-positioned to deliver sustainable long-term growth and shareholder value.” 1 GAAP RESULTS First quarter fiscal 2027 revenue was $339.4 million, up 5.6% compared with the first quarter of fiscal 2026." exhibit |
| Q1 FY2027 | "FISCAL 2027 GUIDANCE The Company raised its previous fiscal 2027 GAAP revenue and organic revenue growth guidance as follows: Total Company Previous Guidance Current Guidance Reported Revenue 4 - 7% 5 - 8% 53rd week impact (~2%) (~2%) Currency impact 0 - 1% 0 - 1% Organic Revenue (1) 3 - 6% 4 - 7% Adjusted operating margin 50 – 100 bps expansion YoY 50 – 100 bps expansion YoY Adjusted earnings per diluted share Comparable to reported revenue growth Comparable to reported revenue growth Free cash flow conversion (2) ~80% ~80% __________ (1) Previous guidance includes approximately low-single-di" exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/HAE
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/HAE
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/HAE/"><img src="https://veritasdata.dev/embed/HAE.svg" alt="HAE earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/HAE/)
Script
<script async src="https://veritasdata.dev/embed/HAE.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/HAE"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.